@inbook{100422,
  author = {Bajaj H and Agarwal S and Sharma A and Yadav M and Naseer MA},
  title = {Current Therapeutic Strategies for Trachoma},
  abstract = {<jats:p>As a result of persistent follicular conjunctivitis brought on by Chlamydia
trachomatis and consequent corneal scarring, about 6 million people have irreparable
blindness. Chlamydia trachomatis is a bacterium that causes trachoma, an eye
infection. Early signs include eyelid itchiness and irritation, whereas advanced signs
include swollen eyelids, pus oozing from the eyes, photophobia (light sensitivity),
discomfort in the eye, and vision issues. Using the SAFE strategy, the WHO is driving
an international campaign to eradicate Blinding Trachoma. Trichiasis surgery,
antibiotic treatment for infection, hygiene promotion on the face, and environmental
changes to improve air quality are all part of this. The best antibacterial medication for
widespread distribution is oral azithromycin.</jats:p>},
  year = {2024},
  journal = {Emerging Approaches to Tackle Neglected Diseases: From Molecule to End Product},
  pages = {182-199},
  publisher = {BENTHAM SCIENCE PUBLISHERS},
  isbn = {9789815196863},
  doi = {10.2174/9789815196863124010011},
}